Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.

This bill creates the New Jersey Active Pharmaceutical Ingredient (API) Regulatory Commission to oversee API manufacturing within the state and ensure quality standards for APIs made elsewhere that enter New Jersey. The commission, composed of 17 members including pharmaceutical industry experts, state health and economic development officials, and non-voting legislative representatives, will establish manufacturing standards, promote growth of New Jersey's API industry using federal funding opportunities, and serve as a liaison between the pharmaceutical sector and state/federal governments. It will adopt necessary rules, receive federal funds, and conduct public hearings to carry out its duties. The commission directly affects API manufacturers operating in New Jersey and the broader pharmaceutical industry seeking state support for federal funding programs.